CR Bard Picks Up Bellwether Win In Vein Filter Defect Suit

Law360, New York (June 7, 2012, 8:03 PM EDT) -- An Arizona state jury has found that a C.R. Bard Inc. vein filter is not defective and that the company did not act negligently, the medical giant said Thursday, handing it a decisive victory in the first of the suits over the device to go to trial.

Plaintiff Rosemary Everett claimed in a consolidated action that Bard's first-generation Interior Vena Cava Recovery Filter System was prone to failure. She was implanted with the device, used to prevent blood clots caused by surgery, and in less than...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.